Site Reference ID/Investigator# 26406 — DeSoto, Texas

Site Reference ID/Investigator# 26406 is a clinical research site located in DeSoto, Texas, United States 75115.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 26406 has participated in 1 clinical trials.

Therapeutic areas: Cognitive Deficits in Schizophrenia.

Sponsors: AbbVie (prior sponsor, Abbott).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in DeSoto

Browse all research sites in Texas · View every site in DeSoto

• The Cedars Hospital, InSite Clinical Research
• InSite Clinical Research
• Epic Medical Research
• Epic Medical Research - DeSoto
• Research Site
• Alkermes Investigational Site
• Adams Clinical Dallas
• Pfizer Investigational Site
• Neurocrine Clinical Site
• GSK Investigational Site
• Retina Specialists
• Clinical Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 26406?

Site Reference ID/Investigator# 26406 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 26406 conducted?

Site Reference ID/Investigator# 26406 has 1 clinical trials on record. Their work covers Cognitive Deficits in Schizophrenia.

Is Site Reference ID/Investigator# 26406 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 26406 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 26406?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.